Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin dips 5.7% to $77,620 but shows signs of recovery amid profit-taking by long-term holders.

Market News
09 Sep 2026
AMBCrypto
View Source
Bullish
Bitcoin dips 5.7% to $77,620 but shows signs of recovery amid profit-taking by long-term holders.

Bitcoin experienced a 5.7% price drop from $82,300 to $77,620 over five days but has started to rebound, rising 2.4% from its recent low. Despite long-term holders selling and taking profits, Bitcoin's price remains strong above the $76,000 demand zone, supported by increased open interest in derivatives and bullish market structure. The $82,000 resistance zone remains critical to watch, with upcoming CPI reports and rate hike expectations likely to increase volatility.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
41 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
S&P 500 shows dot-com bubble-like risks with high valuation and narrow rally in tech and energy sectors.

S&P 500 shows dot-com bubble-like risks with high valuation and narrow rally in tech and energy sectors.

The S&P 500 currently exhibits a high CAPE valuation of 41x and a market concentration reminiscent of the dot-com bubble peak, with the rally primarily driven by tech and energy sectors. This narrow market breadth raises systemic risk concerns simila...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App